Pacira shares rose 44% in Thursday's session, but the article gives no reason or company update. The share move alone does not change Pacira's business outlook.
A share-price jump does not show that Pacira sold more medicine or changed its business. The article gives no reason for the move and reports no company results, product news, or deal terms. This report alone does not change how we read Pacira's business.
Onconetix shares rose 34% during Thursday's session, but the article reports no company news. The share move alone does not change its business outlook.
Shuttle Pharmaceuticals shares rose 18% during Thursday's session, but the article reports no company news. The share move alone does not change its business outlook.
GridAI Technologies shares rose 18% during Thursday's session, but the article reports no company news. The share move alone does not change its business outlook.
Haemonetics shares rose 18% during Thursday's session, but the article reports no company news. The share move alone does not change its business outlook.
Veradermics shares rose 16% during Thursday's session, but the article reports no company news. The share move alone does not change its business outlook.
Follow Pacira BioSciences (PCRX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PCRX